Search - tctmd.com

Displaying 41 - 60 of 465

Sort: Relevancy | Date

Presentation TCT 2025

Under Pressure: Treating Hypertension with Renal Denervation

Presenter: David P. Lee

October 25, 2025

Presentation TCT India 2025

Renal Denervation: Patient Selection/Technical Aspects

Presenter: Ajay J. Kirtane

July 27, 2025

Presentation TCT India 2025

Renal Denervation: Patient Selection/Technical Aspects

Presenter: Ajay J. Kirtane

July 26, 2025

Presentation Fellows 2025

Renal Denervation for Hypertension: What You Need to Know

Presenter: Jay S. Giri

May 18, 2025

Presentation Miami Valves 2025

Initial Experience with the Symplicity Spiral Catheter for Renal Artery Denervation in the Dominican Republic

Presenter: Marcos Domínguez Vargas

January 30, 2025

Presentation TCT 2024

TCT 707: Percutaneous Renal Denervation in the Management of Kidney-Related Pain Syndromes: A Case Series

Presenter: Kari Saville

October 30, 2024

Presentation TCT 2024

Debate Pro: RDN Could Be Useful for the Majority of Patients with Uncontrolled HTN

Presenter: Raymond Townsend

October 29, 2024

Presentation TCT 2024

Debate Pro: Predictors of Efficacy are Not Needed for Most Patients

Presenter: Michael Weber

October 29, 2024

Presentation TCT 2024

Debate Con: Predictors of Efficacy are Sorely Needed in the RDN Space!

Presenter: Eric Secemsky

October 29, 2024

Presentation TCT 2024

What Evaluation is Required for Patient Selection for RDN?

Presenter: Naomi Fisher

October 29, 2024

Presentation TCT 2024

How to Set Up Your RDN Hypertension Program: Team Members and Patient Flow

Presenter: Michael Bloch

October 29, 2024

Presentation TCT 2024

What’s Next - Going into 2025

Presenter: Vijay Iyer

October 28, 2024

Presentation TCT 2024

Science of Ultrasound RDN

Presenter: Michael Joner

October 28, 2024

Presentation TCT 2024

Getting Started: Establishing a Patient Care Pathway

Presenter: Matheen Khuddus

October 28, 2024

Presentation TCT 2024

Building Real-world Clinical Evidence: Global Paradise System (GPS) Registry

Presenter: Naomi Fisher

October 28, 2024

Presentation TCT 2024

Ultrasound Renal Denervation in Hypertension – From Paradise to Sonivie

Presenter: Naomi Fisher

October 28, 2024

Presentation TCT 2024

Radiofrequency Renal Denervation in Hypertension – From Symplicity to Iberis HTN

Presenter: Lucas Lauder

October 28, 2024

Presentation TCT 2024

Multiorgan Denervation in Hypertension and Beyond – From Renal to Hepatic

Presenter: Raven Voora

October 28, 2024

Presentation TCT 2024

Alternative Renal Denervation Devices – From Ablative Solutions to Verve

Presenter: Michael Weber

October 28, 2024

Presentation TCT 2024

Final Results of the Novel Healing-Targeted DES With Synchronized Antiproliferative Drug Delivery to Target Smooth Muscle Cell Proliferation After DES Implantation in Coronary Artery Disease: 5-Year Results of the PIONEER III Trial

Presenter: Thomas Sharp

October 28, 2024

Advertisement

Under Pressure: Treating Hypertension with Renal Denervation

Renal Denervation: Patient Selection/Technical Aspects

Renal Denervation: Patient Selection/Technical Aspects

Renal Denervation for Hypertension: What You Need to Know

Initial Experience with the Symplicity Spiral Catheter for Renal Artery Denervation in the Dominican Republic

TCT 707: Percutaneous Renal Denervation in the Management of Kidney-Related Pain Syndromes: A Case Series

Debate Pro: RDN Could Be Useful for the Majority of Patients with Uncontrolled HTN

Debate Pro: Predictors of Efficacy are Not Needed for Most Patients

Debate Con: Predictors of Efficacy are Sorely Needed in the RDN Space!

What Evaluation is Required for Patient Selection for RDN?

How to Set Up Your RDN Hypertension Program: Team Members and Patient Flow

What’s Next - Going into 2025

Science of Ultrasound RDN

Getting Started: Establishing a Patient Care Pathway

Building Real-world Clinical Evidence: Global Paradise System (GPS) Registry

Ultrasound Renal Denervation in Hypertension – From Paradise to Sonivie

Radiofrequency Renal Denervation in Hypertension – From Symplicity to Iberis HTN

Multiorgan Denervation in Hypertension and Beyond – From Renal to Hepatic

Alternative Renal Denervation Devices – From Ablative Solutions to Verve

Final Results of the Novel Healing-Targeted DES With Synchronized Antiproliferative Drug Delivery to Target Smooth Muscle Cell Proliferation After DES Implantation in Coronary Artery Disease: 5-Year Results of the PIONEER III Trial

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content